Moderna raises revenue guidance

Statements (10 of 13)

1. ▲ Bullish

   Moderna raised full-year 2026 revenue growth guidance to 15% to 25%.

   nasdaq.comNov 9, 2026 01:19 UTCHigh importance
2. ▲ Bullish

   Moderna raised its year-end guidance.

   investors.comNov 6, 2026 18:13 UTCHigh importance
3. ▲ Bullish

   Moderna reported a sales beat for the year.

   investors.comNov 6, 2026 18:13 UTCHigh importance
4. ● Neutral

   Moderna is turning a profit as research and development spending falls.

   nasdaq.comNov 6, 2026 16:58 UTC
5. ▲ Bullish

   Moderna is raising its revenue forecast for 2026.

   valor.globo.comNov 6, 2026 16:18 UTCHigh importance
6. ▲ Bullish

   Moderna raised its outlook for future performance.

   247wallst.comNov 6, 2026 16:05 UTCHigh importance
7. ▲ Bullish

   Moderna reported a profit, reversing a forecasted loss.

   247wallst.comNov 6, 2026 16:05 UTCHigh importance
8. ▲ Bullish

   Moderna reported a small profit in its first profitable quarter in two years

   endpoints.newsNov 6, 2026 13:02 UTC
9. ▲ Bullish

   Moderna raised its 2026 guidance

   breakingthenews.netNov 6, 2026 12:11 UTCHigh importance
10. ▲ Bullish

    Moderna increased its revenue guidance for Covid vaccine sales

    bloomberg.comNov 6, 2026 11:45 UTC

3 more statements on this development this week. The API returns all of them: GET /v2/statements?topic_id=90d6caf8-bba1-4344-8cea-0253d6874026 Get a free API key ↗